MS News That Caught My Eye Last Week: MMJ Chewing Gum, Hair Loss, Botox for Bladder Problems, MS Progression Prediction

MS News That Caught My Eye Last Week: MMJ Chewing Gum, Hair Loss, Botox for Bladder Problems, MS Progression Prediction

Hair Loss Seen in RRMS Patients Using Aubagio Often Temporary and Mild, Study Says

I read a lot of questions on multiple sclerosis (MS) social media groups from people who are worried about hair loss caused by their disease-modifying therapy (DMT). Aubagio (teriflunomide) is one DMT with a known hair loss side effect. (Fortunately, I didn’t notice any loss when I was treated with Aubgio). This real-world study, paid for by the company that markets Aubagio, should be reassuring to those Aubagio patients whose hair is thinning.

Interested in MS research? Check out our forums and join the conversation!

Hair thinning in relapsing-remitting multiple sclerosis (RRMS) patients using Aubagio is usually mild and temporary and does not require stopping treatment, a small real-world study reports.

The research, “Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?,” was published in the journal Neurology and Therapy.


Low-dose Botox Treatment Improves Urinary Symptoms in MS Patients, Study Finds

I hope that this Phase 3 trial moves into an approval for this treatment because I’d certainly love to have something that would improve my bladder problems. This treatment, a monthly injection of low-dose Botox, seems to be a patient-friendly way to ease such issues without some of the complications the higher dose presents.

Results from a Phase 3 clinical trial show that urinary symptoms can be reduced significantly after treatment with low-dose Botox (100 units) in patients with MS.

That finding was reported in the study “Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS,” published in the journal Neurology


MedChew RX Shows Stability and Potential for Effectiveness in Early Tests, Company Reports

Many people with MS have reported that some medical marijuana products can help with MS spasticity and muscle cramping. A company is testing MMJ in chewing gum form. It’s working on beginning a clinical trial in Holland soon.

AXIM Biotechnologies announced that tests on its cannabinoid-based chewing gum — MedChew Rx — showed both product stability and effective release of medicinal molecules, with a high percentage of its pharmaceutical ingredients available.

These test results may be of importance, as the company is planning to bring MedChewRx into clinical trials as a treatment for pain and spasticity in MS patients.


Number, Location, Size of Lesions on MRI Can Predict Progression to MS, Study Shows

It’s becoming more evident, research shows, that early treatment is a key to slowing MS progression. But, as known by many of us whose diagnosis took a long time, pinning a specific MS diagnosis can be tough. This study suggests that counting, locating, and measuring lesions on an MRI scan can do a lot to help confirm a diagnosis.

The number, location, and size of lesions can help predict the risk of progression from clinically isolated syndrome (CIS) to MS within one year, a new study shows.

The study, “MRI in predicting conversion to multiple sclerosis within 1 year,” was published in the journal Brain and Behavior.


Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.


    • Itasara says:

      I was taking a hair skin and nail suppliment. Then I saw an article or more that biotin
      Is not effective. I take a lot of suppliments including collagen so I stopped the other. They were a bit expensive considering all the money I already spend on suppliments.

  1. Alan Davies says:

    I was diagnosed with PPMS in Dec 2013, but now haven’t had a MRI scan for about three years. How often should I expect to have a scan?

    • Ed Tobias says:

      It’s difficult to say, Alan, since everyone with MS is different. I’ve had an MRI once a year for many years, but it’s really a question for you to ask your neurologist.


  2. itasara says:

    My neurologist said since I was doing so well the Copaxone was working so he saw no reason to have an MRI after initial ones in 2005 and 7. This year he said I should probably get one done so after 11 yrs I did in April. It looked similar-all inactive- but suggested I see a specialist. I’ve decided to continue with the specialist
    and she has me scheduled for another MRI in November. I think in individual cases MRIs needed be done frequently but waiting so long isn’t a good idea bc it is difficult then to know when any changes occurred. True though that MRI and symptoms don’t necessarily agree.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This